Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1
Active, not recruiting
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2018-04-13
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Kathryn Gold
- Target Recruit Count
- 24
- Registration Number
- NCT03498378
- Locations
- 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States
News
No news found